Cancel
See Linkedin
Known information
- Has over 15 years of industry experience building teams and technologies in aerospace, brain machine interfacing, synthetic biology, and drug discovery/development
- Built and co-led a group at Neuralink that developed and prototyped the next-generation neural interface
- Served as VP of Engineering, Computational Biology and Drug Development at Loyal, where he directed multiple groups to execute the largest ever epigenetic study in dogs
- Developed the final formulation of Loyal’s lead molecule and wrote the statistical plan for the first ever lifespan extension pivotal study
- Led multiple successful partnerships with established institutions and companies
- Holds patents related to his work
About Olio Labs
Olio Labs is a remote healthcare company specializing in AI-driven drug discovery and delivery, focusing on developing combination therapeutics for obesity with reduced side effects.
Report inaccurate information
